Cough is defined as a modern hybrid strain, though its exact origins remain undocumented. Breeders have not publicly confirmed a definitive lineage, and historical records regarding its development are thin or incomplete; while it is sometimes associated with NL5 and Haze genetics, the veracity of this cross remains a subject of debate within the community. Due to this lack of formal documentation, the specific breeder responsible for the strain’s emergence is not part of the established record, leaving its foundational history largely a matter of speculation rather than verified fact.

The terpene profile of Cough is led by terpinolene, followed in intensity by myrcene, ocimene, caryophyllene, beta-pinene, and limonene, with trace amounts of pinene, alpha-terpinene, gamma-terpinene, humulene, eucalyptol, and nerolidol. Because this profile is based on confirmed lab data, it provides a consistent, albeit complex, sensory foundation. Users can expect an experience defined by this particular sequence, which contributes to the strain's overall aromatic and flavor characteristics. Cannabinoid content is characterized as THC-dominant, with an estimated average of 22.9% THC, while CBD and CBG levels are estimated to be negligible at roughly 0%.

Cough is bred to reach maturity after 63 days of flowering, demonstrating a high yield potential that makes it suitable for both indoor and outdoor cultivation environments. Despite its moderate growth difficulty, the plant remains a functional choice for cultivators aiming for consistent production. In terms of user experience, it induces reported effects of being relaxed, happy, and uplifted. These characteristics make the strain a common selection for those seeking relief from stress and pain, or aid for sleep, though no notable offspring have been recorded to date.